Searched for
QUINOLONE
Typhoid bacteria more resistant to antibiotics now: Lancet studyAccording to the study, quinolone-resistant strains accounted for more than 85% of S Typhi (the bacteria that causes Typhoid fever) in Bang...- You need not always complete full course of antibiotics: DoctorsIn many situations, stopping antibiotics sooner is a safe way to reduce antibiotic overuse, said a paper published in the British Medical J...
- From cultivation to consumer waste, here's how tobacco life cycle impacts usTobacco is often grown without rotation with other crops, so plants require intensive use of fertilisers & pesticides.
- TB treatment could be shortened, show trialsThe effectiveness of the four-month regimen was proved on the basis of recurrence levels, number of patients testing negative in sputum sme...
- Venus Remedies gets Mexico patent for PotentoxGranted by the Mexican Institute of Industrial Property, the patent protects the composition of Potentox, the company said.
- Venus gets US patent for antibiotic productVenus Remedies has got US patent for Potentox, used for pneumonia other infections and is looking at increasing presence in the $ 12 bn ant...
- Elder Pharma sets up division to tap rural marketsElder Pharmaceuticals has earmarked a Rs 40-crore investment for a rural thrust and set up a dedicated division called 'Elvista' to spread ...
- Elder Pharma to step up rural focusElder Pharmaceuticals is increasing its focus on the rural market.
- Ranbaxy is India's biggest pharma firmRanbaxy has emerged as the leader in the domestic pharmaceutical retail market, with a share of 5.2% for the April to June quarter. Insuran...
- Anu's Laboratories IPO to hit market on May 12Anu's Laboratories plans to enter the capital market on May 12 with its initial public offering of 38,20,000 equity shares at a price to be...
- Wockhardt takes Nadoxin patent case to high courtDomestic pharma major Wockhardt has filed a case with the Bombay High Court, after the Indian Patent office rejected its patent application...
- Wockhardt moves HC for patent lawThe case will reopen the debate on value of incremental innovation as cos seek clarity on patent law.
- Wockhardt's product refused patentThe patent office in Mumbai has rejected Wockhardt’s application for a product patent for its product - nadifloxacin - a topical antibiotic...
- Wockhardt signs in-licensing agreement with UK's LSIWockhardt has signed an in-licensing agreement with LSI, a UK-based company specialising in dermatology, to market Vitix, a patented produc...
Load More
